期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
From monogenic lupus to TLR7/MyD88-targeted therapy 被引量:1
1
作者 Min Wang yezi peng +1 位作者 Hao Li Xuan Zhang 《The Innovation》 2022年第5期29-30,共2页
TLR7 MUTATIONS PREDISPOSE INDIVIDUALS TO SLE Systemic lupus erythematosus(SLE),a complicated autoimmune disease with multiple organ involvement,is characterized by excessive autoantibody production and immune complex ... TLR7 MUTATIONS PREDISPOSE INDIVIDUALS TO SLE Systemic lupus erythematosus(SLE),a complicated autoimmune disease with multiple organ involvement,is characterized by excessive autoantibody production and immune complex deposition.According to the European League Against Rheumatism and the American College of Rheumatology classifications of SLE,clinical manifestations and immunological indicators are two major criteria for lupus classification.A 7-year-old patient presented by Brown et al.exhibited thrombocytopenia,hypocomplementemia,and elevated autoantibodies,which are critical serological features of lupus.1 Moreover,damage to diverse tissues including joints,kidneys,and neurological systems was observed.Altogether,this patient was diagnosed with pediatric lupus.Additionally,this individual responded well to current SLE therapies including prednisone,azathioprine,mycophenolate,and rituximab.Various etiologies,including genetic predisposition and environmental factors。 展开更多
关键词 LUPUS TLR7 INVOLVEMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部